Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures

(2022) Simona Lattanzi et al.   EPILEPSIA

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study

(2022) Simona Lattanzi et al.   Neurology and Therapy

Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial

(2021) Manuel Toledo et al.   EPILEPSY & BEHAVIOR

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

(2021) Simona Lattanzi et al.   CNS DRUGS

Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis

(2020) Christian Brandt et al.   EPILEPSY & BEHAVIOR

Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy

(2020) Bshra Ali A. Alsfouk et al.   JAMA Neurology

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial

(2020) Terence J. O’Brien et al.   EPILEPSIA

Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: post-hoc analysis of a randomized, placebo-controlled trial

(2020) Pavel Klein et al.   EPILEPSY RESEARCH

Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg disease: An open-label, long-term follow-up trial

(2020) Elinor Ben-Menachem et al.   EPILEPSY RESEARCH

Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy

(2016) Pavel Klein et al.   EPILEPSIA

Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures

(2016) Manuel Toledo et al.   EPILEPSIA

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures

(2012) Simon Borghs et al.   EPILEPSY & BEHAVIOR